News | News By Subject | News by Disease News By Date | Search News

Bone cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Tiny Promedior To Present Positive Phase 2 Myelofibrosis Data Next Week     5/30/2014
Amgen (AMGN), UCB, Inc. (UCBJF.PK): Osteoporosis Phase 2 Drug Trial A Success     1/3/2014
Sanofi (France) (SAN.PA) Suffers Another Setback, Ditches Late-Stage Bone Marrow Cancer Drug     11/19/2013
National Institute for Clinical Excellence (NICE) Rejects Pfizer Inc. (PFE)'s Bone Cancer Drug     7/17/2013
FDA Approves Amgen (AMGN)'s Xgeva to Treat Giant Cell Tumor of the Bone     6/13/2013
Genmab A/S (GEN.CO) Rises as Danske Sees FDA Breakthrough     2/15/2013
Novartis AG (NVS)'s Jakavi Turned Down by National Institute for Clinical Excellence (NICE) for Blood Cancer     2/13/2013
Bayer HealthCare (BAY) Gets FDA Priority Review for Cancer Drug     2/13/2013
Merck & Co., Inc. (MRK) Withdraws MAA for Bone Cancer Treatment     11/30/2012
Amgen (AMGN) Stock Direction Hinges on Bone Cancer Data     10/8/2010
Incyte Corporation (INCY) Shares Fall As Some Analysts Say Bone Marrow Drug Treats Symptoms, Not Disease Itself     6/4/2008
Celgene Corporation (CELG) Withdraws Revlimid Application In Europe Following Negative Recommendation     6/2/2008

News from Around the Web
Top Pharma Lobbyist Showers Praise on Biogen (BIIB) for Being Anti-Shkreli Like     2/22/2017
Researchers Investigate 'Friendly Bacteria' to Kill Bone Cancer Cells, University of Nottingham Study     10/12/2010
Approved Lymphoma Drug Shows Promise In Early Tests Against Bone Cancer, University of Rochester Medical Center Study     11/6/2009
Pain Pills May Cut Risk Of Bowel Cancer, National Institute of Environmental Health Sciences Study     12/29/2008
Bowel Cancer Link To Stem Cells, Cardiff University And Hubrecht Institute Study     12/22/2008
Promising New Drug Blocks Mutation In Bone Marrow Cancers, Oregon Health & Science University (OHSU) Study     12/15/2008
Medical College of Wisconsin Researchers Studying Cryoablation To Relieve Metastatic Bone Pain in Cancer Patients     5/20/2008
Potential Brain Cancer Drug For Children May Damage Bones, Children's Hospital of Philadelphia Research     3/11/2008
Freezing Bone Cancer Tumors Reduces Pain, Mayo Clinic Study Shows     11/28/2007
Phase II Study Shows HRPC Patients with Bone Metastases See Improved Survival with ZD4054     9/26/2007
Low Levels of Common Enzyme Key to Resistance in Ewing's Sarcoma     5/23/2007
"Trojan Horse" Agent Halts Bone Metastasis In Mice     11/15/2006
Protein Linked To Cancer Spread Identified     3/29/2006
University of Florida Scientists Say Stem Cells May Trigger Bone Cancer     11/23/2005
Dentist Hid Fluoride-Cancer Link     6/29/2005

Press Releases
FDA Advisory Committee Unanimously Recommends Approval Of Genentech (RHHBY)’s Subcutaneous Rituximab For Certain Blood Cancers     3/29/2017
Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2015 Operational And Financial Results     8/11/2015
NYU Langone Medical Center Release: Key Mechanism Identified In Pediatric Bone Cancers That Allows Proliferation Of Tumor-Forming Stem Cells     4/2/2015
Advaxis, Inc. To Initiate Clinical Development Of ADXS-Cher2 Immunotherapy To Treat Pediatric Bone Cancer     5/5/2014
AB Science (AB.PA): Final Results Of Phase 3 Mastocytosis Study Expected By End Of 2014     11/12/2013
Genzyme Corporation (GENZ) Convenes 1st International Gaucher Conference on Bone Disease     7/1/2013
EXINI and Active Biotech AB (BTPC) Present Impact of Tasquinimod on Bone Metastases as Measured by Bone Scan Index (BSI)     6/3/2013
AlphaMed Release: Stem Cells From Fat Outperform Those From Bone Marrow in Fighting Disease     5/21/2013
Techpool In-Licenses China Rights to Bone Cancer Drug From Roche (RHHBY)     12/21/2012
Medivir AB (MVIRb.F) Has Initiated a Phase I Clinical Trial With Its Cathepsin K inhibitor MIV-711     5/29/2012
Exelixis, Inc. (EXEL) Announces Initiation of Phase 2 Investigator-Sponsored Trial of Cabozantinib in Women with Hormone Receptor-Positive Metastatic Breast Cancer and Bone Metastases     11/21/2011
Roche (RHHBY) Release: International Research Studies Underscore Utility, Robustness of 454 Sequencing Systems for Characterizing Blood Cancers     12/7/2010
Amgen (AMGN) Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa(R)     10/11/2010
Afferent Pharmaceuticals Presents Data Supporting Use of P2X3 Antagonists in Reducing Bone Cancer Pain     9/1/2010
Merrion Pharmaceuticals, Inc. is Issued a Key U.S. Patent for Orazol(TM), Their Lead Product to Treat Bone Metastases Associated With Prostate, Breast and Other Cancers     5/7/2010